Bloomfield, D J <br/><br/>
Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 1998 
 - 1218-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1998.16.3.1218  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics, Non-Narcotic--therapeutic use<br/>Bone Neoplasms--complications<br/>Breast Neoplasms--pathology<br/>Clodronic Acid--therapeutic use<br/>Diphosphonates--therapeutic use<br/>Evidence-Based Medicine<br/>Female<br/>Humans<br/>Male<br/>Multiple Myeloma--complications<br/>Pain--drug therapy<br/>Pamidronate<br/>Practice Guidelines as Topic<br/>Prostatic Neoplasms--pathology<br/>Randomized Controlled Trials as Topic